Know Your Market: US and EU Regulatory Expectations for Combination Products
Watch the webinar
Key learnings
- Differences in regulation between the US and EU for combination products.
- The impact of new regulatory guidance on the market space.
- Considerations regarding usability studies and clinical trials.
- The potential need for strategies to address bridging studies.
- The co-existence of design control and drug development activities.
Speakers

Audrey Toulemonde

Thomas Stover, Ph.D.
Complete the form below to access the recording.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.